Recruiting

Exercise Regimen

Sponsor:

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Code:

NCT06083324

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 20 - 70+

Healthy Volunteers: Not accepted

Interventions

Dose escalated resistance training

Study Details

Brief summary:

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.

Conditions

Cancer

Study ID

NCT06083324

Start date

Feb 3, 2023

Status verified date

Jul, 2026

Completion date

Jan 16, 2028

Anticipated

Primary completion date

Jan 16, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 20 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age 20-89 years
2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI
4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel.
5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere

Exclusion Criteria:

1\. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

General cancer patients

All patients undergoing treatment for cancer on an exercise regimen

Head and neck cancer patients

All patients undergoing treatment for head and neck cancer on an exercise regime

Colorectal cancer patients

All patients undergoing treatment for colorectal cancer on an exercise regime

Pancreatic cancer patients

All patients undergoing treatment for pancreatic cancer on an exercise regime

Metastatic breast cancer patients

All patients undergoing treatment for metastatic breast cancer on an exercise regime

Interventions

Dose escalated resistance training

All individuals will be engaging in resistance training during and/or after their cancer treatment

Primary outcome measure

  • Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis [ Time Frame: 3 months ]
  • Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound [ Time Frame: 3 months ]
  • Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]

Central Contacts and Locations

Central contacts

Samantha Campbell

(412) 330-6151samantha.campbell@ahn.org

Locations

AHN CI Exercise Oncology and Resiliency Center

Recruiting

Pittsburgh, Pennsylvania, United States, 15202

Contacts

Colin E Champ, MD, CSCS

412-734-7605colin.champ@ahn.org

More Information

Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Last update posted

Jul 8, 2026

Last verified

Jul, 2026

Keywords

  • exercise
  • resistance training

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) on 2026-07-08.